OREANDA-NEWS. Chrystal Capital, the London based independent corporate finance firm specialising in alternative sources of funding, is pleased to announce that, in conjunction with leading AIM broker finnCap, it has successfully raised 9.6m pounds through a placing for Constellation Healthcare Technologies, Inc.  ("Constellation Healthcare") (AIM:CHT). The market capitalisation of Constellation Healthcare is approximately 75 million pounds at the placing price.

Constellation Healthcare and its subsidiaries provide outsourced revenue cycle management, practice management and group purchasing services to the physician market in the United States.

Chrystal Capital has a demonstrable track record of successfully raising capital at IPO for companies operating across different sectors and in multi-national jurisdictions.

Chrystal Capital has relationships with a significant number of single and multi-family offices, who are increasingly looking to make direct investment into public companies. Hence, Chrystal Capital is an adviser that can attract investment from a long-term and supportive investor base.  These family investors coupled with niche and mainstream financial institutions, lead to a well-balanced list of shareholders that are supportive of the ambitions of UK listed companies.

Commenting on the deal, James Innes, Partner at Chrystal Capital, said: "We have once again demonstrated our ability to add significant value to the IPO process, both in terms of our advisory capacity and raising of capital from our network of investors. We are delighted to have been involved in the IPO of Constellation Healthcare and anticipate substantial growth in the business as Paul Parmar and his team look to execute their M&A strategy in the US."

Paul Parmar, CEO of Constellation Healthcare, also added: "We are pleased to have worked with Chrystal Capital throughout the full process of Constellation Healthcare's IPO on AIM, from inception to completion. Chrystal Capital's access to alternative sources of funding has been invaluable and we look forward to working with the team in future.